✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹91 Cr.
P/E
29.88
  • Onyx Biotec
  • Suven Pharma
  • JB Chem & Pharma
FAQs on Onyx Biotec Ltd. Shareprice

There is not enough historical data for the companies share price.

Onyx Biotec is not expensive.
Latest PE of Onyx Biotec is 29.91, while 3 year average PE is 38.28.
Also latest EV/EBITDA of Onyx Biotec is 0 while 3yr average is 16.35.

Growth Table
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Balance Sheet
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Cash Flow
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Quarterly Results
  • Onyx Biotec Ltd.
  • Suven Pharma
  • JB Chem & Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Onyx Biotec Ltd. Financials

Balance sheet of Onyx Biotec is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Onyx Biotec is increasing.
Latest debt of Onyx Biotec is ₹28.65 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹27.86 Crs.

Yes, profit is increasing.
The profit of Onyx Biotec is ₹4.59 Crs for TTM, ₹3.03 Crs for Mar 2024 and ₹1.84 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onyx Biotec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech